AWARDDEFINITIVE CONTRACTOther than small business
Definitive contract 75N93022C00060BLACKSMITH MEDICINES, INC.
Overview
Award facts
- Net obligations
- $14.56M
- $14,562,694of $22.11M potential value
- Period of performance
- Sep 21, 2022 to Jun 13, 2027
- Ends in 6 months
- Modifications
- 17
- Latest action Nov 12, 2026
- Contract type
- Definitive contract
- PIID 75N93022C00060
Description of requirement
FG-2101: A FIRST-IN-CLASS LPXC INHIBITOR FOR THE TREATMENT OF MDR GRAMNEGATIVE URINARY TRACT INFECTIONS.
Dates and value
- Award date
- Signed on Sep 21, 2022
- Current value
- $14,562,694Base and exercised options
- Potential value (if all options are exercised)
- $22,107,848
Obligations by fiscal year of action
- FY2027: $1,601,612
- FY2026: $1,983,173
- FY2024: $6,265,409
- FY2022: $4,712,500
Total across 4 fiscal years: $14,562,694
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Nov 12, 2026. View on USAspending · Recipient on SAM.gov
Recipient
LocationSAN DIEGO, CA
UEIZCWKWSWHAJD6
CAGE code6XVV8
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyBLACKSMITH MEDICINES INC.
Business types and certifications
For-profit organizationCorporation (not tax-exempt)
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NIAID
- Funded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NIAID
Place of performance
- Place of performance
- San Diego, California 92121-1143
- Congressional district (place of performance)
- CA-50As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH (research and development)
Competition
- Extent competed
- Full and open competitionA
- Solicitation procedures
- Negotiated proposal/quoteNP
- Set-aside
- No set-aside used
- Contract pricing
- Cost plus fixed feeU
- Offers received
- 30
Solicitation and notices
- Solicitation ID
- PHS-2021-1
- Solicitation date
- Feb 23, 2021
- Notices
- Award Notice posted Jul 1, 2021
- Solicitation posted Sep 25, 2020
- Solicitation posted Jul 28, 2020
- Presolicitation posted Jul 9, 2020
Contract details
- Subcontracting plan
- Plan not included - no subcontracting possibilitiesA
- Cost Accounting Standards clause
- No - CAS waiver approvedN
- Certified cost or pricing data
- Yes
- Service Contract Act labor standards
- No
- Commercial procedures
- Commercial products/services procedures not usedD
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
- Performance-based service acquisition
- No - service where PBA is not used.N
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Sep 21, 2022Base obligation at award: $4,712,500
- Latest action
- Nov 12, 2026 — Supplemental agreement (within scope)Modification P00017; obligation change +$1,601,612
- Latest substantive action
- Nov 12, 2026 — Supplemental agreement (within scope)Modification P00017; obligation change +$1,601,612
- Latest funding action
- Apr 9, 2026 — Funding onlyModification P00015; obligation change +$1,154,161; funding only: changes obligations, not scope
- Actions by type
- Base award1
- Supplemental agreement (within scope)12
- Option exercised2
- Funding only1
- Other administrative action1
- Vendor identifier change (novation)1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Pricing and financing
- Paid by purchase card
- No
- Latest action: change in base and exercised options
- $1,601,612
- Latest action: change in base and all options
- $1,601,612
Socio-economic and policy
- Inherently governmental functions
- Other functionsOT
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
- Walsh-Healey Act (materials and supplies)
- No
- Construction wage rates (Davis-Bacon)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- Definitive contractD
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7529
- Contracting office code
- 75N930
- Transactions recorded under this award key
- 18
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7529
- Funding office code
- 75N930